Corporate News     01-Jun-15
Orchid Chemicals & Pharmaceuticals announces change in directorate
With effect from 28 May 2015
Orchid Chemicals & Pharmaceuticals announced that Sundaram Yuvaraj has vacated his office pursuant to Section 167(b) of the Companies Act 2013 from the Board of Orchid and R. Kannan has been inducted into the Board of the Company as a Non-Executive, Independent director with effect from 28 May 2015.
Previous News
  Orchid Pharma reports consolidated net loss of Rs 6.59 crore in the March 2022 quarter
 ( Results - Announcements 13-May-22   07:54 )
  Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter
 ( Results - Announcements 13-Aug-24   07:29 )
  Orchid Pharma Ltd leads gainers in 'B' group
 ( Hot Pursuit - 09-Feb-24   12:15 )
  Orchid Pharma to convene board meeting
 ( Corporate News - 07-Feb-22   10:23 )
  Orchid Pharma hits 52 week high on recording nearly 4x jump in Q3 PAT
 ( Hot Pursuit - 09-Feb-24   12:58 )
  Orchid Pharma reports consolidated net profit of Rs 49.40 crore in the September 2021 quarter
 ( Results - Announcements 15-Nov-21   15:49 )
  Orchid Pharma and Orchid Bio Pharma signs MoU to obtain license for 7ACA technology
 ( Corporate News - 04-Mar-23   10:20 )
  Orchid Chemicals & Pharmaceuticals to hold board meeting
 ( Corporate News - 13-Feb-15   10:10 )
  Orchid Pharma to conduct board meeting
 ( Corporate News - 17-May-24   14:12 )
  Orchid Pharma receives Establishment Inspection Report for formulations facility in Sriperumbudur
 ( Corporate News - 18-Apr-17   14:13 )
  Orchid Chemicals & Pharmaceuticals announces change in nominee director
 ( Corporate News - 07-Jan-16   13:45 )
Other Stories
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
  Transformers & Rectifiers India wins order of Rs 565 cr
  03-Oct-24   09:07
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
Back Top